October 22, 2015

POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 1, 2017

    Valeant Securities Fraud Case Lives, Could Lose Debt Claims

    A New Jersey federal judge allowed a multibillion-dollar securities class action against Valeant Pharmaceuticals International Inc. and its top officials to move forward on Friday, although claims related to $15 billion in corporate debt that was issued under allegedly fraudulent pretenses may be cut.

5 other articles on this case. View all »

Parties

To view the parties, register now.